A detailed history of State Street Corp transactions in Exscientia PLC stock. As of the latest transaction made, State Street Corp holds 25,152 shares of EXAI stock, worth $121,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,152
Previous 24,648 2.04%
Holding current value
$121,735
Previous $125,000 2.4%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.26 - $6.0 $2,147 - $3,024
504 Added 2.04%
25,152 $122,000
Q1 2024

May 15, 2024

SELL
$5.3 - $7.51 $18,587 - $26,337
-3,507 Reduced 12.46%
24,648 $140,000
Q2 2023

Aug 14, 2023

SELL
$4.79 - $8.3 $2,409 - $4,174
-503 Reduced 1.76%
28,155 $166,000
Q1 2023

May 15, 2023

SELL
$5.3 - $10.93 $667 - $1,377
-126 Reduced 0.44%
28,658 $151,000
Q4 2022

Feb 14, 2023

BUY
$4.1 - $8.94 $541 - $1,180
132 Added 0.46%
28,784 $153,000
Q3 2022

Nov 15, 2022

BUY
$7.27 - $12.92 $208,300 - $370,183
28,652 New
28,652 $235,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.